P J Blanchet - JoVE Visualize

Showing results (21-30 of 38) with videos related to

Pageof 4

Sort By:

Brain Research. Molecular Brain Research|July 1, 1996

L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeysJ J Soghomonian, S Pedneault, P J Blanchet, et al.

Clinical Neuropharmacology|June 8, 2001

Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxismG J Lavigne, J P Soucy, F Lobbezoo, et al.

Amino Acids|January 1, 1999

Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's diseaseL Verhagen Metman, P Del Dotto, P J Blanchet, et al.

Experimental Neurology|October 24, 1998

Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavengerP J Blanchet, S Konitsiotis, K Hyland, et al.

Molecular Pharmacology|November 1, 1996

Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanineM Morissette, M Goulet, F Calon, et al.

Neurochemistry International|July 14, 1999

Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA contentF Calon, M Morissette, M Goulet, et al.

Annals of Neurology|April 13, 2000

Molecular basis of levodopa-induced dyskinesiasF Calon, R Grondin, M Morissette, et al.

Experimental Neurology|April 29, 2000

125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatmentsF Calon, M Morissette, M Goulet, et al.

Neuroscience|July 1, 1997

Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysisM Goulet, M Morissette, F Calon, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999

Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeysP J Blanchet, S Konitsiotis, E R Whittemore, et al.

Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:

Pageof 4

Brain Research. Molecular Brain Research|July 1, 1996

L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeysJ J Soghomonian, S Pedneault, P J Blanchet, et al.

Clinical Neuropharmacology|June 8, 2001

Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxismG J Lavigne, J P Soucy, F Lobbezoo, et al.

Amino Acids|January 1, 1999

Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's diseaseL Verhagen Metman, P Del Dotto, P J Blanchet, et al.

Experimental Neurology|October 24, 1998

Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavengerP J Blanchet, S Konitsiotis, K Hyland, et al.

Molecular Pharmacology|November 1, 1996

Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanineM Morissette, M Goulet, F Calon, et al.

Neurochemistry International|July 14, 1999

Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA contentF Calon, M Morissette, M Goulet, et al.

Annals of Neurology|April 13, 2000

Molecular basis of levodopa-induced dyskinesiasF Calon, R Grondin, M Morissette, et al.

Experimental Neurology|April 29, 2000

125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatmentsF Calon, M Morissette, M Goulet, et al.

Neuroscience|July 1, 1997

Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysisM Goulet, M Morissette, F Calon, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999

Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeysP J Blanchet, S Konitsiotis, E R Whittemore, et al.

Pageof 4